Related references
Note: Only part of the references are listed.Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
Richard H. Haubrich et al.
AIDS (2009)
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
Priscilla Y. Hsue et al.
AIDS (2009)
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Colleen F. Kelley et al.
CLINICAL INFECTIOUS DISEASES (2009)
Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study
Tristan Ferry et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression
Esteban Martinez et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Continuous Viral Escape and Selection by Autologous Neutralizing Antibodies in Drug-Naive Human Immunodeficiency Virus Controllers
Madhumita Mahalanabis et al.
JOURNAL OF VIROLOGY (2009)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
Jonathan A. C. Sterne et al.
LANCET (2009)
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Reuben M. Granich et al.
LANCET (2009)
When to Start Antiretroviral Therapy - Ready When You Are?
Paul E. Sax et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Mari M. Kitahata et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Challenge of Finding a Cure for HIV Infection
Douglas D. Richman et al.
SCIENCE (2009)
Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation
Martin Vogel et al.
CURRENT OPINION IN HIV AND AIDS (2009)
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
Steven G. Deeks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
A. d'Arminio Monforte et al.
AIDS (2008)
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial
W. M. El-Sadr et al.
ANNALS OF INTERNAL MEDICINE (2008)
Epidemiological Evidence for Cardiovascular Disease in HIV-Infected Patients and Relationship to Highly Active Antiretroviral Therapy
Judith S. Currier et al.
CIRCULATION (2008)
A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy
Jason B. Dinoso et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antiretroviral treatment of adult HIV infection - 2008 recommendations of the International AIDS Society USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Antiretroviral therapy of late presenters with advanced HIV disease
Manuel Battegay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study
Sean Emery et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and erntricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
Jean-Michel Molina et al.
LANCET (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
Class-sparing regimens for initial treatment of HIV-1 infection
Sharon A. Riddler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area
E. Martinez et al.
HIV MEDICINE (2007)
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection
Benigno Rodriguez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts:: A EuroSIDA study
Daria Podlekareva et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel
Scott M. Hammer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
HIV-1 viral load blips are of limited clinical significance
PK Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Treatment for adult HIV infection - 2004 recommendations of the International AIDS Society-USA panel
PG Yeni et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy
CA Sabin et al.
AIDS (2004)
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
F García et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
CL Thio et al.
LANCET (2002)
Antiretroviral treatment for adult HIV infection in 2002 - Updated recommendations of the international AIDS Society-USA panel
PG Yeni et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors:: a prospective cohort study
E Martinez et al.
LANCET (2001)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
CCJ Carpenter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
